Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 89909168 | 8990916 | 8 | F | 20080701 | 20160722 | 20121231 | 20160728 | EXP | PHHY2012CA120973 | NOVARTIS | 70.67 | YR | F | Y | 0.00000 | 20160728 | CN | COUNTRY NOT SPECIFIED | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 89909168 | 8990916 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 400 MG, BID | 22068 | 400 | MG | CAPSULE | BID | ||||||
| 89909168 | 8990916 | 2 | SS | TASIGNA | NILOTINIB | 1 | Oral | 150 MG, BID | 22068 | 150 | MG | CAPSULE | BID | ||||||
| 89909168 | 8990916 | 3 | C | PREDNISONE. | PREDNISONE | 1 | Unknown | U | 0 | ||||||||||
| 89909168 | 8990916 | 4 | C | PREDNISONE. | PREDNISONE | 1 | U | 0 | |||||||||||
| 89909168 | 8990916 | 5 | C | BABY ASPIRIN | ASPIRIN | 1 | Unknown | U | 0 | ||||||||||
| 89909168 | 8990916 | 6 | C | BABY ASPIRIN | ASPIRIN | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 89909168 | 8990916 | 1 | Chronic myeloid leukaemia |
| 89909168 | 8990916 | 3 | Chronic obstructive pulmonary disease |
| 89909168 | 8990916 | 4 | Lung disorder |
| 89909168 | 8990916 | 5 | Chronic obstructive pulmonary disease |
| 89909168 | 8990916 | 6 | Lung disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 89909168 | 8990916 | OT |
| 89909168 | 8990916 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 89909168 | 8990916 | Balance disorder | |
| 89909168 | 8990916 | Dizziness | |
| 89909168 | 8990916 | Dyspepsia | |
| 89909168 | 8990916 | Headache | |
| 89909168 | 8990916 | Muscular weakness | |
| 89909168 | 8990916 | Oropharyngeal pain | |
| 89909168 | 8990916 | Pneumonia | |
| 89909168 | 8990916 | Speech disorder | |
| 89909168 | 8990916 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 89909168 | 8990916 | 1 | 20080701 | 0 | ||
| 89909168 | 8990916 | 2 | 2009 | 0 |